Results 181 to 186 of about 10,664 (186)

Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes

Expert Review of Clinical Immunology, 2010
Michael F Mcdermott
exaly  

Canakinumab in Schnitzler Syndrome

Seminars in Arthritis and Rheumatism, 2013
Steven Vanderschueren
exaly  

Canakinumab

Reactions Weekly, 2015
openaire   +2 more sources

Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial

Diabetes and Metabolism, 2013
exaly  

Canakinumab

Reactions Weekly, 2014
openaire   +1 more source

Canakinumab

2013
openaire   +1 more source